» Articles » PMID: 9430220

Functionally and Structurally Distinct NK Cell Receptor Repertoires in the Peripheral Blood of Two Human Donors

Overview
Journal Immunity
Publisher Cell Press
Date 1998 Jan 16
PMID 9430220
Citations 211
Authors
Affiliations
Soon will be listed here.
Abstract

The expression of KIR and CD94:NKG2 receptors was determined for more than 100 natural killer (NK) cell clones obtained from two blood donors who differ in their HLA class I and KIR genes. More than 98% of the clones were inhibited by individual autologous class I allotypes, and every clone was inhibited by the combination of autologous allotypes. The patterns of inhibition correlate with expression of inhibitory receptors of defined specificity. One donor possesses three class I ligands for KIR, and a majority of NK cells use KIR as their inhibitory receptor; the second donor possesses only a single ligand for KIR, and a majority of NK cells use the more broadly reactive CD94:NKG2a as their inhibitory receptor. Because of these differences, the first donor has subpopulations of NK cells that kill cells of the second donor, whereas the NK cells of the second donor are universally tolerant of cells from the first donor.

Citing Articles

CD8α and CD70 mark human natural killer cell populations which differ in cytotoxicity.

Rey C, Jones K, Stacey K, Evans A, Worboys J, Howell G Front Immunol. 2025; 16:1526379.

PMID: 40046047 PMC: 11880019. DOI: 10.3389/fimmu.2025.1526379.


Expression of NKp46 and other activating inhibitory receptors on uterine endometrial NK cells in females with various reproductive failures: A review.

Mai C, Fukui A, Saeki S, Takeyama R, Yamaya A, Shibahara H Reprod Med Biol. 2025; 24(1):e12610.

PMID: 39807425 PMC: 11725765. DOI: 10.1002/rmb2.12610.


KLRD1 (CD94): A Prognostic Biomarker and Therapeutic Candidate in Head and Neck Squamous Cell Carcinoma.

Dong C, Lin Z, Hu Y, Lu Q J Cancer. 2025; 16(3):982-995.

PMID: 39781341 PMC: 11705060. DOI: 10.7150/jca.104762.


Natural killer cells for pancreatic cancer immunotherapy: Role of nanoparticles.

Kumar V, Mahato R Cancer Lett. 2023; 579:216462.

PMID: 37924937 PMC: 10842153. DOI: 10.1016/j.canlet.2023.216462.


The KIR2DL1 intermediate upstream element participates in gene activation.

Wright P, Li H, Rahman M, Anderson E, Karwan M, Carrell J Immunogenetics. 2023; 75(6):495-506.

PMID: 37801092 PMC: 10651540. DOI: 10.1007/s00251-023-01321-9.